Alejandra Carvajal
General Counsel, Dare Bioscience, Inc.
Companies
- CytomX Therapeutics, Inc.General counsel Aug 5, 2026 to now1
- Mersana Therapeutics (United States)General counsel Apr 28, 2021 to now2
- Dare Bioscience, Inc.General counsel Jun 30, 2015 to Jan 9, 20173
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CytomX Therapeutics, Inc. CTMX100,000 shares4$230.0K at $2.30Aug 3, 2026
- Mersana Therapeutics (United States)0 shares5Jan 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 3, 2026Granted 100,000 shares of CytomX Therapeutics, Inc.4
- Jan 6, 2026U 3,131 shares of Mersana Therapeutics (United States)5
- Jan 16, 2025Sold 5,096 shares at $0.58 of Mersana Therapeutics (United States)6
- Jan 15, 2025Sold 952 shares at $0.63 of Mersana Therapeutics (United States)7
- Jan 15, 2025Exercised options 12,500 shares of Mersana Therapeutics (United States)6
- Jan 14, 2025Sold 3,330 shares at $0.66 of Mersana Therapeutics (United States)8
- Jan 14, 2025Exercised options 2,500 shares of Mersana Therapeutics (United States)7
- Jan 13, 2025Exercised options 8,958 shares of Mersana Therapeutics (United States)8
- Oct 3, 2024Sold 5,598 shares at $1.96 of Mersana Therapeutics (United States)9
- Oct 2, 2024Sold 8,089 shares at $2.00 of Mersana Therapeutics (United States)9
- Oct 1, 2024Exercised options 50,000 shares of Mersana Therapeutics (United States)9
- Jan 16, 2024Sold 4,381 shares at $2.71 of Mersana Therapeutics (United States)10
- Jan 14, 2024Exercised options 2,500 shares of Mersana Therapeutics (United States)10
- Jan 13, 2024Exercised options 8,958 shares of Mersana Therapeutics (United States)10
- Apr 27, 2023Sold 3,944 shares at $3.89 of Mersana Therapeutics (United States)11
- Apr 26, 2023Exercised options 13,250 shares of Mersana Therapeutics (United States)11
- Jan 17, 2023Sold 782 shares at $5.74 of Mersana Therapeutics (United States)12
- Jan 14, 2023Exercised options 2,500 shares of Mersana Therapeutics (United States)12
- Apr 26, 2022Sold 3,948 shares at $3.69 of Mersana Therapeutics (United States)13
- Apr 26, 2022Exercised options 13,250 shares of Mersana Therapeutics (United States)13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Jan 17, 2025
- 7SEC EDGARForm 4 filed Jan 16, 2025
- 8SEC EDGARForm 4 filed Jan 15, 2025
- 9SEC EDGARForm 4 filed Oct 7, 2024
- 10SEC EDGARForm 4 filed Jan 17, 2024
- 11SEC EDGARForm 4 filed Apr 28, 2023
- 12SEC EDGARForm 4 filed Jan 18, 2023
- 13SEC EDGARForm 4 filed Apr 28, 2022